Tao Huang

Hunan Provincial Center for Disease Control and Prevention

SCHOLARLY PAPERS

2

DOWNLOADS

94

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Safety and Immunogenicity of Heterologous and Homologous Boosting with Orally Aerosolized or Intramuscular Ad5-nCoV and Inactivated Vaccines in Children and Adolescents: A Randomized, Open-Label, Parallel Controlled, Single-Center Study

Number of pages: 20 Posted: 20 Dec 2022
Hunan Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Hunan Provincial Center for Disease Control and Prevention, Academy of Military Medical Sciences - Institute of Biotechnology, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, CanSino Biologics Inc., Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Hunan Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Government of the People's Republic of China - Beijing Key Laboratory of Pediatric Organ Failure, Beijing Institute of Biotechnology, CanSino Biologics Inc., CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Hunan Provincial Center for Disease Control and Prevention and Southern Medical University - Neonatal Intensive Care Unit
Downloads 64 (521,965)

Abstract:

Loading...

COVID-19 vaccine, mucosal vaccine, children, adolescents, clinical trial

2.

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell) Inactivated in Patients Over 60 Years of Age With Hypertension and Diabetes Mellitus

Number of pages: 25 Posted: 27 Jan 2022
affiliation not provided to SSRN, China National Biotech Group Company Limited, Peking University - Department of Epidemiology and Biostatistics, Hunan Provincial Center for Disease Control and Prevention, Guizhou Center for Disease Control and Prevention, affiliation not provided to SSRN, China National Biotech Group Company Limited, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, China National Biotech Group Company Limited, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fujian Center for Disease Control and Prevention, Wuhan Institute of Biological Products, Co. Ltd., affiliation not provided to SSRN and National Engineering Technology Research Center of Combination Vaccines
Downloads 30 (702,213)

Abstract:

Loading...

COVID-19 vaccine (Vero cell) inactivated, elderly hypertensive population, elderly diabetic population, safety, immunogenicity